Why should pharma invest in digital products for those living with rare diseases?
pharmaphorum
NOVEMBER 23, 2022
Consultations and clinical trials are often few and far between. New digital products always rely on early adopters to create a community and improve the product. It is this passion and fundamental need for change that suggests digital products can have a higher success rate when supporting rare disease communities.
111 
Let's personalize your content